GPCRStructure Therapeutics Inc.
What is the market doing?
No clear lean: nothing decisive, though in a downtrend (−52% vs 200-day).
In a downtrend, below its 50- and 200-day averages. Oversold (RSI 1). Price is −52% vs its 200-day average.
Moderately shorted, settled Sep 15, 2026, about a week of normal trading to cover. Up 13% since the previous count, up from 2.7% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How GPCR is trading
Structure Therapeutics Inc. is +8.2% over the past year while the S&P 500 is +18%: 10 points behind the market.
1-year return · S&P 500 +18%
- vs 200-day average
- −52%
vs 200-day average · a clear downtrend
- RSI (14)
- 1
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 73%
Below its 52-week high
Details›
- Last close2026-10-09
- $25.51
- 1 monthS&P 500 +2.7%
- −36%
- 1 yearS&P 500 +18%
- +8.2%
- vs 50-day average$42.50
- −40%
- 52-week high
- $93.79
- 52-week low
- $24.01
- Annualised volatility
- 99%
| Year | Return |
|---|---|
| 2026 (year to date) | −63% |
| 2025 | +156% |
| 2024 | −33% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 3 | 3 of 3 | +15% |
| Feb | 3 | 0 of 3 | −19% |
| Mar | 4 | 1 of 4 | −13% |
| Apr | 4 | 2 of 4 | +10% |
| May | 4 | 1 of 4 | −3.0% |
| Jun | 4 | 3 of 4 | +16% |
| Jul | 4 | 0 of 4 | −7.8% |
| Aug | 4 | 2 of 4 | −4.3% |
| Sep | 4 | 3 of 4 | +27% |
| Oct | 4 | 2 of 4 | +10% |
| Nov | 3 | 1 of 3 | −12% |
| Dec | 3 | 1 of 3 | +16% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.